Blue%20Bag%20with%20Cross%20Icon%20Medic

INVESTOR RELATIONS

(TSXV:VPT, OTC:VPTDF)

Ventripoint Diagnostics Ltd is a medical device company that is primarily engaged in the development and commercialization of cardiac diagnostic tools.  It sells its products worldwide.
Green Gradient Technology Professional_B
CAPITAL STRUCTURE

Shares Outstanding        138M
Shares Fully Diluted        145M
Recent Share Price         CDN$.32 (US$.25)
52-Week Range              CDN$.07-.68
Market Cap                      ca. CDN$52M (USD$42M)
Insider Ownership (FD)   6%
Public Float Ownership   94%
Debt                                 None
Cash                                3 years
Liquidity                           CDN$1.0M/day
                                        USD$0.75M/day

Symbol:    TSX-V: VPT    &    OTC: VPTDF

Jan

Feb

Mar

Apr

May

Jun

0.6000

0.4000

0.2000

0.0000

20.00 M

10.0M

0.00

Green Gradient Technology Professional_B
OUR STRATEGY

Staying true to our story, Ventripoint Diagnostics Ltd. continues to be dedicated to developing quality, smart tools that help solve the immediate needs of our healthcare clinicians,  and most importantly improves the clinical experience for our youngest to oldest patient.   

A recent study from the Icahn school of

KEY AND STRATEGIC GOALS

2020

Read full report
Blue%20Marketing%20Start-up%20Business%2

Ventripoint has entered into a collaboration with the Veterinary Hospital at the North Carolina State University (NCSU) to test and evaluate the use of the VMS+ in echocardiography of canines with the goal of expanding this technology to all animals.

VMS+ could eventually help treat our most loyal best friend.

EXPLORING NEW FRONTIERS FOR VMS+
Read More
LATEST PRESS RELEASES
Green Gradient Technology Professional_B

April 20, 2021

Ventripoint Attends 23rd Annual Canadian Echo Weekend and Grants Stock Options

April 19, 2021

Ventripoint Extends Patent Portfolio with Foundational U.S. Provisional Patent Filing
of Heart Motion Tracking Technology

Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices

April 27, 2021

Green Gradient Technology Professional_B
LATEST EVENTS

JUNE
22

Ventripoint Diagnostics Update with George Adams and Alvira Macanovic

JUNE
10

Ventripoint Diagnostics Update and Q&A with George Adams, Alvira Macanovic and Dr. Mark Swaim

MAY
26

Ventripoint Diagnostics Update and Q&A with Dr. George Adams

FEB

11

Ventripoint CEO interviewed on TraderTV Live

Ventripoint CEO interviewed by Torrey Hills Capital

Green Gradient Technology Professional_B

MAR

25

FEB

11

Ventripoint CEO interviewed by Torrey Hills Capital

MAY

13

BioPub/Torrey Hills Capital  Zoom Webinar

Topic: Ventripoint: Bigger and Better, with CEO Dr. George Adams

APR
28

Ventripoint Diagnostics Update - Overview & Update on GE Health Collaboration

APR

25

Ventripoint Diagnostics Update

MAR

25

Ventripoint CEO interview on BioPub

FEB

11

Ventripoint CEO interviewed on TraderTV Live

FEB

04

Ventripoint CEO interviewed by Torrey Hills Capital

Green Gradient Technology Professional_B
INVESTOR RELATIONS TEAM
Jonathan Robinson
Oak Hill Financial Inc.
(416) 669-1001
JRobinson@oakhillfinancial.ca
Adrian Sydenham
MarketSmart Communications Inc.
(877) 261-4466
Info@marketsmart.ca
SUBSCRIBE FOR